EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Vaccines as Immunotherapies for Substance Use Disorders

Thomas R Kosten

American Journal of Psychiatry · 2024

DOI: 10.1176/appi.ajp.20230828 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Psychiatry, 2024. Verfasst von Thomas R Kosten. Beteiligte Einrichtung: Waggoner Professor of Psychiatry, Pharmacology, Neuroscience, Immunology, Baylor College of Medicine, Houston. Hauptthemen laut MEDLINE: Fentanyl, Vaccines, Substance-Related Disorders. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substance use disorders (SUD) present a worldwide challenge with few effective therapies except for the relative efficacy of opioid pharmacotherapies, despite limited treatment access. However, the proliferation of illicit fentanyl use initiated a dramatic and cascading epidemic of lethal overdoses. This rise in fentanyl overdoses regenerated an interest in vaccine immunotherapy, which, despite an optimistic start in animal models over the past 50 years, yielded disappointing results in human clinical trials of vaccines against nicotine, stimulants (cocaine and methamphetamine), and opioids. After a brief review of clinical and selected preclinical vaccine studies, the "lessons learned" from the previous vaccine clinical trials are summarized, and then the newest challenge of a vaccine against fentanyl and its analogs is explored. Animal studies have made significant advances in vaccine technology for SUD treatment over the past 50 years, and the resulting anti-fentanyl vaccines show remarkable promise for ending this epidemic of fentanyl deaths.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylVaccinesSubstance-Related DisordersHumansAnimalsImmunotherapyOpioid-Related DisordersDrug Overdose

Stichwörter der Autor:innen

Immune FunctionNicotineOpioidsPharmacotherapyStimulantsSubstance-Related and Addictive Disorders

Substanzen

FentanylVaccines

Autor:innen und Institutionen

  • Waggoner Professor of Psychiatry, Pharmacology, Neuroscience, Immunology, Baylor College of Medicine, Houston.

Zitieren

APA

Kosten, T. R. (2024). Vaccines as Immunotherapies for Substance Use Disorders. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20230828

Vancouver

Kosten TR. Vaccines as Immunotherapies for Substance Use Disorders. American Journal of Psychiatry. 2024. doi:10.1176/appi.ajp.20230828

BibTeX
@article{Kosten2024,
  author = {Kosten, Thomas R},
  title = {Vaccines as Immunotherapies for Substance Use Disorders},
  journal = {American Journal of Psychiatry},
  year = {2024},
  doi = {10.1176/appi.ajp.20230828}
}
Kostenlos starten →